-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
BriaCell Therapeutics Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2021 to Q3 2024.
- BriaCell Therapeutics Corp. Operating Income (Loss) for the quarter ending October 31, 2024 was -$5.15M, a 39.4% increase year-over-year.
- BriaCell Therapeutics Corp. Operating Income (Loss) for the twelve months ending October 31, 2024 was -$30M, a 13.7% decline year-over-year.
- BriaCell Therapeutics Corp. annual Operating Income (Loss) for 2024 was -$33.3M, a 43.2% decline from 2023.
- BriaCell Therapeutics Corp. annual Operating Income (Loss) for 2023 was -$23.3M, a 52.2% decline from 2022.
- BriaCell Therapeutics Corp. annual Operating Income (Loss) for 2022 was -$15.3M, a 119% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)